[1]. K.L. Stanhope, J.M. Schwarz, N.L. Keim, S.C. Griffen, A.A. Bremer, J.L. Graham, B. Hatcher, C.L. Cox, A. Dyachenko, W. Zhang, J.P. McGahan, A. Seibert, R.M. Krauss, S. Chiu, E.J. Schaefer, M. Ai, S. Otokozawa, K. Nakajima, T. Nakano, C. M.K. Beysen, Hellerstein, L. Berglund, P.J. Havel. Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Invest. 119, (2009) 1322–1334.
[2]. S.L. Ménard, E. Croteau, O. Sarrhini, R. Gélinas, P. Brassard, R. Ouellet, M. Bentourkia, J.E. van Lier, C. Des Rosiers, R. Lecomte, A.C. Carpentier. Abnormal in vivo myocardial energy substrate uptake in diet-induced type 2 diabetic cardiomyopathy in rats. Am. J. Physiol. Endocrinol. Metab. 298 (2009) E1049–1057.
[3]. T. Nakayama, T. Kosugi, M. Gersch, T. Connor, L.G. Sanchez-Lozada, M.A. Lanaspa, C. Roncal, S.E. Perez-Pozo, R.J. Johnson, T. Nakagawa. Dietary fructose causes tubulointerstitial injury in the normal rat kidney. Am. J. Physiol. Renal. Physiol. 298 (2010) F712–720
[4]. M. Chung, J. Ma, K. Patel, S. Berger, J. Lau, A.H. Lichtenstein. Fructose, high-fructose corn syrup, sucrose, and non alcoholic fatty liver disease or indexes of liver health: A systematic review and meta-analysis. Am. J. Clin. Nutr. 100 (2014) 833–849.
[5]. S. Chiu, J.L. Sievenpiper, R.J. de Souza, A.I. Cozma, A. Mirrahimi, A.J. Carleton, V. Ha, M. Di Buono, A.L. Jenkins, D.J. Jenkins. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of controlled feeding trials. Eur. J. Clin. Nutr. 68 (2014) 416–423.
[6]. Softic, S. D.E. Cohen, C.R. Kahn, Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease. Dig. Dis. Sci. 61 (2016) 1282–1293.
[7]. N. Alkhouri, L.J. Dixon, A.E. Feldstein, Lipotoxicity in nonalcoholic fatty liver disease: Not all lipids are created equal. Expert. Rev. Gastroenterol. Hepatol. 3 (2009)445–451.
[8]. H. Malhi, G.J. Gores. Cellular and Molecular Mechanisms of Liver Injury. Gastroenterology 134 (2008) 1641–1654.
[9]. A. Guilherme, J. V. Virbasius, V. Puri, M. P. Czech. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9 (2008) 367–377
[10]. O. Osborn, J.M. Olefsky. The cellular and signaling networks linking the immune system and metabolism in disease. Nat.Med. 2012;18:363–374
[11]. A. Chawla, K.D. Nguyen, Y.P.S. Goh Macrophage-mediated inflammation in metabolic disease. Nat. Rev. Immunol. 11 (2011) 738–749
[12]. T. Nakamura, M. Furuhashi, P. Li, H. Cao, G. Tuncman, N. Sonenberg, C.Z. Gorgun, G.S. Hotamisligil. Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis. Cell. 140 (2010) 338–348.
[13]. M.A. Carvalho-Filho, B.M. Carvalho, A.G. Oliveira, D. Guadagnini, M. Ueno, M.M. Dias, D.M. Tsukumo, S.M. Hirabara, L.F. Reis, R. Curi, J.B. Carvalheira, M.J. Saad. Double-stranded RNA-activated protein kinase is a key modulator of insulin sensitivity in physiological conditions and in obesity in mice. Endocrinology. 153 (2012) 5261-5274.
[14]. M.P. Udumula, B. Medapi, I. Dhar, A. Bhat, K. Desai, D. Sriram, A. Dhar. The Small Molecule Indirubin-3'-Oxime Inhibits Protein Kinase R: Antiapoptotic and Antioxidant Effect in Rat Cardiac Myocytes. Pharmacology. 97 (2016) 25-30.
[15]. M.P. Udumula, A. Bhat, S. Mangali, J. Kalra, I. Dhar, D. Sriram, A. Dhar. Pharmacological evaluation of novel PKR inhibitor indirubin-3-hydrazone in-vitro in cardiac myocytes and in-vivo in wistar rats. Life. Sci. 209 (2018) 85-96.
[16]. R. D. Wilson and M. S. Islam, “Fructose-fed streptozotocin-injected rat: An alternative model for type 2 diabetes,” Pharmacol. Reports, vol. 64, no. 1, pp. 129–139, 2012.
[17] S. Ray, A. Talukdar, N. Sonthalia, M. Saha, S. Kundu, D. Khanra, S. Guha, A.K. Basu, A. Mukherjee, D. Ray, S. Ganguly. Serum lipoprotein ratios as markers of insulin resistance: a study among non-diabetic acute coronary syndrome patients with impaired fasting glucose. Indian J Med Res. 141 (2015) 62-7.
[18] N. A. Iwani, M. Y. Jalaludin, R. M. Zin, M. Z. Fuziah, J. Y. Hong, Y. Abqariyah, A. H. Mokhtar, & W. M. Wan Nazaimoon (2017). Triglyceride to HDL-C Ratio is Associated with Insulin Resistance in Overweight and Obese Children. Scientific reports, 7, 40055.
[19] Yeh WC, Tsao YC, Li WC, Tzeng IS, Chen LS, Chen JY. Elevated triglyceride-to-HDL cholesterol ratio is an indicator for insulin resistance in middle-aged and elderly Taiwanese population: a cross-sectional study. Lipids Health Dis. 2019 Oct 11;18(1):176.
[20]. Abdelmalek MF, Suzuki A, Guy C, Unalp‐Arida A, Colvin R, Johnson RJ, Diehl AM, Nonalcoholic Steatohepatitis Clinical Research Network. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology. 2010 Jun;51(6):1961-71.
[21] Lozano I, Van der Werf R, Bietiger W, Seyfritz E, Peronet C, Pinget M, Jeandidier N, Maillard E, Marchioni E, Sigrist S, Dal S. High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications. Nutrition & metabolism. 2016 Dec;13(1):1-3.
[22] R. Bryk et. al. Identification of new inhibitors of protein kinase R guided by statistical modeling. Bioorg. Med. Chem. Lett. 21 (2011) 4108-4114.
[23] M.P. Udumula, S.B. Mangali, A. Bhat, I. Dhar, D. Sriram, A. Dhar. High glucose impairs insulin signaling via activation of PKR pathway in L6 muscle cells. Biochem. Biophys. Res. Commun. 486 (2017) 645-651.
[24] G Wei , H Sun , JL Liu , K Dong , J Liu , M Zhang . Indirubin, a small molecular deriving from connectivity map (CMAP) screening, ameliorates obesity-induced metabolic dysfunction by enhancing brown adipose thermogenesis and white adipose browning. Nutrition & metabolism. 17-1(2020) 1-8.
[25] B.T. Yang, T.A. Dayeh, P.A. Volkov, C.L. Kirkpatrick, S. Malmgren, X. Jing, E. Renström, C.B. Wollheim, M.D. Nitert, C. Ling. Increased DNA methylation and decreased expression of PDX-1 in pancreatic islets from patients with type 2 diabetes. Mol. Endocrin. 26 (2012) 1203-1212.
[26] J.L. Evans, B.A. Maddux, I.D. Goldfine. The molecular basis for oxidative stress-induced insulin resistance. Antioxid. Redox. Signal. 7-8 (2005) 1040-1052.
[27] S. Mangali, et al. Upregulation of PKR pathway mediates glucolipotoxicity induced diabetic cardiomyopathy in vivo in wistar rats and in vitro in cultured cardiomyocytes. Biochem Pharmacol. 177 (2020):113948.
[28]. Huang BW, Chiang MT, Yao HT, Chiang W. The effect of high‐fat and high‐fructose diets on glucose tolerance and plasma lipid and leptin levels in rats. Diabetes, Obesity and Metabolism. 2004 Mar;6(2):120-6.
[29]. H. Ohkawa, N. Ohishi, K. Yagi. Assay for Lipid Peroxides in Animal Tissues Thiobarbituric Acid Reaction. 358 (1979) 351–358.